CSIMarket
 
Clearmind Medicine Inc   (NASDAQ: CMND)
Other Ticker:  
 
 
Price: $1.1400 $0.00 0.000%
Day's High: $1.14 Week Perf: 4.59 %
Day's Low: $ 1.12 30 Day Perf: -18.57 %
Volume (M): 13 52 Wk High: $ 2.30
Volume (M$): $ 15 52 Wk Avg: $1.34
Open: $1.12 52 Wk Low: $0.95



 Market Capitalization (Millions $) 0
 Shares Outstanding (Millions) 0
 Employees 1
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -9
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Clearmind Medicine Inc
We were incorporated in the State of Delaware on May 28, 2014 and are a development stage company. Our company is developing an online service www.caleminder.net that provides a calendar- based greeting and reminder service to assist subscribers in remembering important life events such as birthdays, anniversaries, etc.

Users will register with the system and enter these important dates as well as configure a variety of settings, including when they want to be notified, for example one month prior, two weeks prior, one week prior, etc. Currently the application is web based and not for a mobile download application.



   Company Address: 101 ? 1220 West 6th Avenue Vancouver 0
   Company Phone Number: 536.1016   Stock Exchange / Ticker: NASDAQ CMND


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ALZN        43.94% 
ATAI        2.82% 
CMPS   -3.89%    
KTTA        5.61% 
SAGE        2.34% 
XENE        2.42% 
• View Complete Report
   



Clinical Study

Psychedelic Pioneers Clearmind Medicines Bold Steps in Alcohol Use Disorder Treatment Trials,

Published Thu, Oct 10 2024 12:07 PM UTC

Pioneering Psychedelic Frontiers: Clearmind Medicine s Strategic Leap in Alcohol Use Disorder Treatment Trials Clearmind Medicine Inc. has taken significant strides toward transforming the landscape of alcohol use disorder (AUD) treatment by embracing psychedelic-derived therapeutics. The company, listed on various exchanges including Nasdaq and CSE (under the symbol CMND), ...

Announcement

Clearmind Medicines Pioneering Ibogaine Therapy Faces Financial Headwinds in Competitive Biopharma Market,

Published Mon, Sep 16 2024 8:06 PM UTC

Clearmind Medicine: Pioneering Ibogaine Combination Therapy Amid Competitive Market Challenges Clearmind Medicine is a beacon of innovation in the biopharmaceutical industry, yet it faces significant financial headwinds compared to its competitors. In the ever-evolving landscape of biopharmaceutical innovation, Clearmind Medicine Inc. has taken a significant leap forward wi...

Announcement

Clearmind Medicine and Yissum Join Forces for Groundbreaking PTSD Treatment with Revolutionary Psychedelic Compounds...

Published Thu, Sep 12 2024 12:20 PM UTC

Pioneering the Frontier of PTSD Treatment: Clearmind Medicine and Yissum File International Patent for Revolutionary Psychedelic Compounds

Innovative compounds designed to address critical unmet needs in PTSD treatment

In what may be a landmark moment for mental health therapy, Clearmind Medicine Inc (NASDAQ: CMND) and Yissum, the Technology Transfer Compa...

Announcement

Clearmind Medicine The Dichotomy of Innovation Amidst Fiscal Tribulations in Psychedelic Therapeutics,

Published Thu, Aug 29 2024 8:25 PM UTC

Vancouver, Canada, August 29, 2024 In an era of scientific advancement and relentless pursuit of innovative solutions for hitherto inadequately addressed health maladies, Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) hereafter referred to as Clearmind or the Company emerges as a torchbearer of pioneering biotechnology. The distinguished clinical-stage enterprise...

Announcement

Clearmind Medicine Earns U.S. Patent for Binge Behavior Therapy Amidst Financial Struggles,

Published Wed, Aug 21 2024 8:11 PM UTC

Clearmind Medicine Secures U.S. Patent for Binge Behavior Treatment Amid Financial Challenges Vancouver, Canada August 21, 2024 Clearmind Medicine Inc. (Nasdaq: CMND, FSE: CWY0), a clinical-stage biotech company pioneering psychedelic-derived therapeutics, has reached a significant milestone by securing a new patent approval from the United States Patent and Trademark ...










Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com